IDEXX Laboratories, Inc. (IDXX)

NASDAQ: IDXX · IEX Real-Time Price · USD
381.47
-9.38 (-2.40%)
Aug 16, 2022 2:50 PM EDT - Market open
-2.40%
Market Cap 31.76B
Revenue (ttm) 3.31B
Net Income (ttm) 663.95M
Shares Out 83.25M
EPS (ttm) 7.73
PE Ratio 49.35
Forward PE 45.45
Dividend n/a
Ex-Dividend Date n/a
Volume 409,080
Open 387.90
Previous Close 390.85
Day's Range 370.96 - 389.64
52-Week Range 318.50 - 695.18
Beta 1.14
Analysts Buy
Price Target 516.27 (+35.3%)
Earnings Date Aug 2, 2022

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinar... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Jun 21, 1991
CEO Jonathan Jay Mazelsky
Employees 10,000
Stock Exchange NASDAQ
Ticker Symbol IDXX
Full Company Profile

Financial Performance

In 2021, IDXX's revenue was $3.22 billion, an increase of 18.79% compared to the previous year's $2.71 billion. Earnings were $744.85 million, an increase of 28.03%.

Financial Statements

Analyst Forecast

According to 18 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is 516.27, which is an increase of 35.34% from the latest price.

Price Target
$516.27
(35.34% upside)
Analyst Consensus: Buy
Stock Forecasts

News

3 No-Brainer Stocks to Buy in a Correction

Designed to thrive in challenging economic conditions, these companies are great buys during a downturn.

Other symbols: ADBEGOOGGOOGL

IDEXX (IDXX) Q2 Earnings Surpass Estimates, 2022 View Down

IDEXX's (IDXX) Q2 top-line benefits from strong sales at the CAG and Water businesses.

Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 1.30% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

IDEXX Laboratories Announces Second Quarter Results

Achieves second quarter revenue growth of 4% reported and 6.5% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 7% organic, building on high prior year growth Solid demand ...

OCPNY or IDXX: Which Is the Better Value Stock Right Now?

OCPNY vs. IDXX: Which Stock Is the Better Value Option?

3 MedTech Stocks That are Likely to Beat This Earnings Season

MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how STE, TMO and IDXX are poised ahead of their earnings releases.

Other symbols: STETMO

Idexx Laboratories (IDXX) Expected to Beat Earnings Estimates: Should You Buy?

Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive?

Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

7 Wildly Oversold S&P 500 Stocks to Buy Now

These seven S&P 500 stocks to buy have crashed amid 2022's market turmoil and are now set for a swift rebound. The post 7 Wildly Oversold S&P 500 Stocks to Buy Now appeared first on InvestorPlace.

Other symbols: FILMNLENNFLXSWKUA

IDEXX Laboratories to Release 2022 Second Quarter Financial Results

WESTBROOK, Maine , July 8, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 second quarter results for Tu...

The 3 Best Pet Stocks to Buy Now

Pets are a big part of the family in America and that trend is only growing. Here are some top pet stocks to help you profit from the trend.

Other symbols: ELANWOOF

IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive...

IDEXX Reference Laboratories Will Add Fecal Dx Antigen Testing with Flea Tapeworm Detection,  Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service WESTBROOK, Maine , June 21,...

Why Is Idexx (IDXX) Up 0.3% Since Last Earnings Report?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern

Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.

IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day

WESTBROOK, Maine , May 18, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will part...

IDEXX (IDXX) Q1 Earnings Surpass Estimates, Margins Down

Strong sales at the CAG and Water businesses drove IDEXX's (IDXX) first-quarter 2022 revenues.

Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 0.89% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

IDEXX Laboratories Announces First Quarter Results

Achieves first quarter revenue growth of 8% reported and organic, driven by CAG Diagnostics recurring revenue growth of 8% reported and 9% organic, building on high prior year growth Continued strong se...

Why ESG Investing Doesn't Actually Work

The practice of investing based on environmental, social and governance (ESG) criteria has become increasingly popular over the years. Last year was a banner year for cash inflows to ESG funds, with the...

MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA

MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.

Other symbols: CRLNUVA

Earnings Preview: Idexx Laboratories (IDXX) Q1 Earnings Expected to Decline

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

According To Analysts, These 12 Fast-Rising Stocks Are On The Way Up

A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.

Wall Street Thinks This Stock Has 50% Upside

That prediction might be too conservative.

IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists

IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.

IDEXX Laboratories to Release 2022 First Quarter Financial Results

WESTBROOK, Maine , April 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has sch...